Skip to main content
OpenTrials

Clinical trial condition

Agammaglobulinemia

Explore clinical trials studying Agammaglobulinemia. Study availability and eligibility vary by location and protocol.

29 public trials 9 recruiting studies

Agammaglobulinemia trial results

Conditions
Agammaglobulinemia, B-cell Chronic Lymphocytic Leukemia, Bacterial Infections, +25 more
Locations
  • GC2202 Study Site 115 Huntington Park, California, United States
  • GC2202 Study Site 103 St. Petersburg, Florida, United States
  • GC2202 Study Site 111 Bethesda, Maryland, United States
  • GC2202 Study Site 109 Greenville, North Carolina, United States
View all 62 locations
Conditions
Agammaglobulinemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activity) Commack, New York, United States

NCT05584631

Conditions
Agammaglobulinemia, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +28 more
Locations
  • Rutgers, The State University of New Jersey Clinical Research Center New Brunswick, New Jersey, United States
Conditions
Agammaglobulinemia, Blood Protein Disorders, Haematological Malignancy, +16 more
Locations
  • Canberra Hospital Garran, Australian Capital Territory, Australia
  • Concord Hospital Concord, New South Wales, Australia
  • Royal North Shore St Leonards, New South Wales, Australia
  • Monash Medical Centre Clayton, Victoria, Australia